TCM
FMTX

Tekla Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Tekla Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-53,186
Closed -$756K – 181
2021
Q4 		$756K Sell
53,186
-96,639
-65% -$1.67M 0.02% 152
2021
Q3 		$3.47M Hold
149,825
– – 0.11% 122
2021
Q2 		$3.73M Hold
149,825
– – 0.12% 132
2021
Q1 		$4.2M Hold
149,825
– – 0.14% 127
2020
Q4 		$5.23M Buy
+149,825
New +$6.52M 0.18% 117

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Tekla Capital Management's FMTX Position: Q1 2022 in Review

Tekla Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2022, closing a stake of 53,186 shares — an estimated $756K sold.

Tekla Capital Management first reported a position in FMTX in Q4 2020 and held it in 5 quarters. The position peaked at $5.23M in Q4 2020. 98 funds tracked by Wall St. Rank hold FMTX as of Q1 2022.

  • Tekla Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Tekla Capital Management sold 53,186 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2022, an estimated $756K.
  • Tekla Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Tekla Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $5.23M in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on Tekla Capital Management's 13F filing for Q1 2022, filed 13 May 2022.